Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ecker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
A Europe-wide assessment of current medication choices in Huntington's diseaseJosef Priller, Daniel Ecker, Bernhard Landwehrmeyer, et al.
BMC Neurology|June 12, 2009
Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control studyDaniel Ecker, Alexander Unrath, Jan Kassubek, et al.
Neuroscience Letters|December 4, 2003
Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serumSigurd D Süssmuth, Hayrettin Tumani, Daniel Ecker, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 2, 2004
Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysisJan Kassubek, Freimut D Juengling, Daniel Ecker, et al.
Brain : a Journal of Neurology|September 15, 2007
Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRIRobert Christian Wolf, Nenad Vasic, Carlos Schönfeldt-Lecuona, et al.
Human Brain Mapping|January 4, 2008
Cortical dysfunction in patients with Huntington's disease during working memory performanceRobert C Wolf, Nenad Vasic, Carlos Schönfeldt-Lecuona, et al.
Experimental Neurology|July 1, 2008
Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's diseaseRobert Christian Wolf, Fabio Sambataro, Nenad Vasic, et al.
Neuroreport|March 14, 2003
Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI studyJan Kassubek, Hayrettin Tumani, Daniel Ecker, et al.
Basic & Clinical Pharmacology & Toxicology|June 16, 2018
The GRK2 Promoter Is Regulated by Early-Growth Response Transcription Factor EGR-1Stefanie Klenke, Andrea Engler, Daniel Ecker, et al.
Neuroreport|April 13, 2004
Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI studyJan Kassubek, G Bernhard Landwehrmeyer, Daniel Ecker, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
A Europe-wide assessment of current medication choices in Huntington's diseaseJosef Priller, Daniel Ecker, Bernhard Landwehrmeyer, et al.
BMC Neurology|June 12, 2009
Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control studyDaniel Ecker, Alexander Unrath, Jan Kassubek, et al.
Neuroscience Letters|December 4, 2003
Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serumSigurd D Süssmuth, Hayrettin Tumani, Daniel Ecker, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 2, 2004
Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysisJan Kassubek, Freimut D Juengling, Daniel Ecker, et al.
Brain : a Journal of Neurology|September 15, 2007
Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRIRobert Christian Wolf, Nenad Vasic, Carlos Schönfeldt-Lecuona, et al.
Human Brain Mapping|January 4, 2008
Cortical dysfunction in patients with Huntington's disease during working memory performanceRobert C Wolf, Nenad Vasic, Carlos Schönfeldt-Lecuona, et al.
Experimental Neurology|July 1, 2008
Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's diseaseRobert Christian Wolf, Fabio Sambataro, Nenad Vasic, et al.
Neuroreport|March 14, 2003
Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI studyJan Kassubek, Hayrettin Tumani, Daniel Ecker, et al.
Basic & Clinical Pharmacology & Toxicology|June 16, 2018
The GRK2 Promoter Is Regulated by Early-Growth Response Transcription Factor EGR-1Stefanie Klenke, Andrea Engler, Daniel Ecker, et al.
Neuroreport|April 13, 2004
Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI studyJan Kassubek, G Bernhard Landwehrmeyer, Daniel Ecker, et al.
Pageof 2